Table 2 Immune related predicted protein domains.

Mucus advantage (23)

Immunoglobulin I-set (36 h); Immunoglobulin E-set (0 h); Apolipoprotein A1/A4/E (36 h); Immunoglobulin-like domain (36 h); α-2-macroglobulin, conserved site (36 h); α-macroglubulin, receptor-binding (36 h); Complement C1r-like EGF domain (36 h); α-2-macroglobulin, thiolester bond-forming (36 h); Immunoglobulin subtype (36 h); EGF-like,conserved site (36 h); Membrane attack complex component/perforin/complement C9 (36 h); Immunoglobulin-like fold (36 h); Membrane attack complex component/perforin domain, conserved site (36 h); EGF-like calcium-binding domain (36 h); EGF-like calcium-binding, conserved site (36 h); EGF-type aspartate/asparagines hydroxylation site (36 h); C-type lectin fold (36 h); Coagulation factor, subgroup, Gla domain (36 h); C-type lectin fold (36 h); C-type lectin (36 h); Leucine-rich repeat-containing N-terminal (36 h); C-type lectin-like (36 h)

Bile advantage (30)

Immunoglobulin I-set (0 h); Fibringen,α/β/γ chain, C-terminal globular,subdomain 1 (0 h, 36 h); Fibringen,α/β/γ chain, C-terminal globular,subdomain 2 (0 h, 36 h); Fibrinogen,α/β/γ chain, C-terminal globular domain (0 h, 36 h); Fibrinogen, α/β/γ chain, coiled coil domain (0 h, 36 h); Fibrinogen, conserved site (0 h, 36 h); Apolipoprotein A1/A4/E (0 h); Immunoglobulin-like domain (0 h); α-2-macroglobulin, conserved site (0 h); α-macroglubulin, receptor-binding (0 h); Complement C1r-like EGF domain (0 h); α-2-macroglobulin,thiolester bond-forming (0 h); α-2-macroglubulin, N-terminal 2 (0 h); α-macroglobulin complement component (0 h); α-2-macroglobulin (0 h); α-2-macroglobulin,N-terminal (0 h); Immunoglobulin subtype (0 h); EGF-like,conserved site (0 h); Membrane attack complex component/perforin/complement C9 (0 h); Immunoglobulin-like fold (0 h); Membrane attack complex component/perforin domain, conserved site (0 h); EGF-like calcium-binding domain (0 h); EGF-like calcium-binding, conserved site (0 h); EGF-type aspartate/asparagines hydroxylation site (0 h); C-type lectin fold (0 h); Coagulation factor, subgroup, Gla domain (0 h); C-type lectin fold (0 h); C-type lectin (0 h); Leucine-rich repeat-containing N-terminal (0 h); C-type lectin-like (0 h);